Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase IV multicenter single-arm study of Danlong oral liquid for bronchial asthma (heat wheezing syndrome)
CTR20211062Phase 4Active
- Sponsor
- Zhejiang Kangde Pharmaceutical Group
- Start
- Oct 2020
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of Danlong in asthma, sponsored by Zhejiang Kangde Pharmaceutical Group. Started Oct 2020; status: active.
02
Drugs
Danlong
03
Conditions
asthma
Beyond the preview
Go deeper on CTR20211062.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20211062.